CARBOGEN AMCIS France is the Drug Products subsidiary of the CARBOGEN AMCIS group.

As a leading CDMO, CARBOGEN AMCIS helps you to develop your activity through Drug Product & Drug Substance development and Manufacturing. We make our CDMO services available to bring your solutions to life.

« Drug Products » at CARBOGEN AMCIS :

We offer custom development and automated aseptic production of liquid and lyophilized drug products, with a specialization in developing sterile and pyrogen-free parenteral formulations for preclinical and clinical trials (phases I, II and III) and small scale commercial. With this end-to-end service, CARBOGEN AMCIS is your partner of choice for complex and demanding products that require the highest level of quality in our industry.

• Formulation development
• Pre-clinical Batches
• Clinical and Commercial Batches
• Phase I, II, III and commercial

New State of the Art Facility

To answer the demand for fill finish manufacturing capacity, CARBOGEN AMCIS has built a new state-of-the-art facility in St. Beauzire in France. This new facility has two manufacturing lines and can offer both liquid and lyophilized drug product forms.

Highly Potent Capabilities

To compliment the drug substance offering that CARBOGEN AMCIS has, and in line with the rise of Antibody Drug Conjugates (ADC’s) and other highly potent compounds, this new facility is capable of handling products that require the highest containment. This handling capability covers development, manufacturing and release testing, making CARBOGEN AMCIS a great partner for highly potent drug products as well as conventional compounds and biologics.

Expertise, Experience and Flexibility

With over 40 years experience of offering CDMO services, CARBOGEN AMCIS has a good understanding of client needs. We understand that each project is unique and is handled in such a way. Our team of experts bring added value to your project with a pragmatic and knowledgeable approach. With timelines to a manufacturing slot often being very long, CARBOGEN AMCIS can accelerate your drug development pipeline with access to development and manufacturing We are looking forward to hearing how we can support your project. Download the brochure by clicking here

About CARBOGEN AMCIS Group:

CARBOGEN AMCIS is a leading service provider, offering a portfolio of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries at all stages of drug development. Our integrated services for Drug Substances (DS) and Drug Products (DP) provide innovative solutions to support timely and safe drug development.

In addition, the rest of CARBOGEN AMCIS organization provides worldwide a full range of services for the synthesis of the Drug Substance including:

• Process development from first time scale-up to commercial manufacture, production from gram to several hundred kg scale,
• 70 multi-purpose reactors ranging from 6L to 6.300L,
• Extensive capacities for Highly Potent APIs manufacture – Capability to handle up to category 4 + compounds (down to 0,05g/m3),
• Chromatography platform, solid state investigation and crystallization development
• Dedicated laboratory for Bioconjugation and the cGMP Manufacture of ADCs,
• Manufacturing capacities in eightdifferent site (Switzerland, UK, France, The Netherlands and China)

Please do not hesitate to contact us to discuss the details of your project

Website: https://www.carbogen-amcis.com/services/drug-products
Email: drugproduct@carbogen-amcis.com